Cvrx Inc stock is traded at $0.501, with a volume of 519,852. It is down -5.99% in the last 24 hours and down -63.96% over the past month. CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Previous Close:
$0.5329
Open:
$0.5252
24h Volume:
519,852
Relative Volume:
0.60
Market Cap:
$14.27M
Revenue:
$59.07M
Net Income/Loss:
-$52.66M
P/E Ratio:
-
EPS:
-$2.01
Net Cash Flow:
-$40.16M
1W Performance:
-17.52%
1M Performance:
-63.96%
6M Performance:
-91.73%
1Y Performance:
-94.31%
1-Day Range:
$0.4972$0.569
1-Week Range:
$0.4972$0.687
52-Week Range:
$0.4972$10.28
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx IncSector
HealthcareIndustry
Medical DevicesPhone
(763) 416-2850Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS